Daewoong Pharma Cash Flow Quality Index
Daewoong Pharma cash flow quality index. Daewoong Pharma (069620) has a Cash Flow Quality Index of 1.34x as of September 2025. Operating cash flow of ₩57.53 Billion exceeds net income of ₩43.09 Billion, indicating high earnings quality where cash backs reported profits. Explore Daewoong Pharma cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Daewoong Pharma (2007–2024)
Cash flow quality index of Daewoong Pharma from 2007 to 2024. Historical Cash Flow Quality Index for Daewoong Pharma across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 069620 net asset quality score to measure how much of total assets are equity-financed.
Daewoong Pharma Cash Flow Quality Index by Year (2007–2024)
Daewoong Pharma cash flow quality index by year from 2007 to 2024. Year-by-year earnings quality comparison for Daewoong Pharma. For the full cash flow conversion analysis, see Daewoong Pharma operating cash flow efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.38x | ₩51.49 Billion | ₩21.61 Billion | ▲ +114.7% |
| 2023 | 1.11x | ₩132.57 Billion | ₩119.45 Billion | ▼ -28.5% |
| 2022 | 1.55x | ₩118.21 Billion | ₩76.14 Billion | ▲ +57.2% |
| 2021 | 0.99x | ₩39.99 Billion | ₩40.48 Billion | ▼ -96.9% |
| 2020 | 32.17x | ₩100.98 Billion | ₩3.14 Billion | ▲ +1129.1% |
| 2019 | 2.62x | ₩57.60 Billion | ₩22.01 Billion | ▼ -20.5% |
| 2017 | 3.29x | ₩103.94 Billion | ₩31.58 Billion | ▲ +477.2% |
| 2016 | 0.57x | ₩15.38 Billion | ₩26.97 Billion | ▼ -31.8% |
| 2015 | 0.84x | ₩35.89 Billion | ₩42.93 Billion | ▲ +1.6% |
| 2014 | 0.82x | ₩25.95 Billion | ₩31.54 Billion | ▼ -11.3% |
| 2013 | 0.93x | ₩54.16 Billion | ₩58.40 Billion | ▼ -29.8% |
| 2012 | 1.32x | ₩45.02 Billion | ₩34.08 Billion | ▼ -15.9% |
| 2011 | 1.57x | ₩78.82 Billion | ₩50.19 Billion | ▲ +65.1% |
| 2008 | 0.95x | ₩31.33 Billion | ₩32.93 Billion | ▲ +117.3% |
| 2007 | 0.44x | ₩25.81 Billion | ₩58.95 Billion | — |